Home Merck dives into 'superbug' chase with Cubist
 

Keywords :   


Merck dives into 'superbug' chase with Cubist

2014-12-08 17:23:28| Biotech - Topix.net

Merck will spend $8.4 billion to buy Cubist Pharmaceuticals and push deeper into treating so-called "superbugs" that have drawn dire warnings from global health organizations. The company said Monday that the deal will give it stronger footing in hospital acute care and help it address antibiotic resistance, which the Whitehouse Station, New Jersey, drugmaker called a critical area of unmet medical need.

Tags: chase merck dives cubist

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11
27.11PSA10 SSP
27.11
27.11
27.11
27.115
27.11BTR 20()competition
27.11DVD
More »